These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 35914977)

  • 1. CRISPR-Cas12c: a noncleaving DNA binder with minimal PAM requirement.
    Awan MJA; Amin I; Mansoor S
    Trends Biotechnol; 2022 Oct; 40(10):1141-1143. PubMed ID: 35914977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression.
    Huang CJ; Adler BA; Doudna JA
    Mol Cell; 2022 Jun; 82(11):2148-2160.e4. PubMed ID: 35659325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system.
    Zhang B; Lin J; Perčulija V; Li Y; Lu Q; Chen J; Ouyang S
    Nucleic Acids Res; 2022 Nov; 50(20):11820-11833. PubMed ID: 36321657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas12c-DETECTOR: A specific and sensitive Cas12c-based DNA detection platform.
    Wang Z; Zhong C
    Int J Biol Macromol; 2021 Dec; 193(Pt A):441-449. PubMed ID: 34715203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
    Wada N; Osakabe K; Osakabe Y
    Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
    Evans BA; Bernstein DA
    mSphere; 2021 May; 6(3):. PubMed ID: 34011687
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
    Newsom S; Parameshwaran HP; Martin L; Rajan R
    Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAM-less plant genome editing using a CRISPR-SpRY toolbox.
    Ren Q; Sretenovic S; Liu S; Tang X; Huang L; He Y; Liu L; Guo Y; Zhong Z; Liu G; Cheng Y; Zheng X; Pan C; Yin D; Zhang Y; Li W; Qi L; Li C; Qi Y; Zhang Y
    Nat Plants; 2021 Jan; 7(1):25-33. PubMed ID: 33398158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted gene disruption by CRISPR/xCas9 system in Drosophila melanogaster.
    Ni XY; Zhou ZD; Huang J; Qiao X
    Arch Insect Biochem Physiol; 2020 May; 104(1):e21662. PubMed ID: 32027059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
    Zhang D; Zhang B
    Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rewired Cas9s with Minimal Sequence Constraints.
    Levesque S; Agudelo D; Doyon Y
    Trends Pharmacol Sci; 2020 Jul; 41(7):429-431. PubMed ID: 32416935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can SpRY recognize any PAM in human cells?
    Ye J; Xi H; Chen Y; Chen Q; Lu X; Lv J; Chen Y; Gu F; Zhao J
    J Zhejiang Univ Sci B; 2022 May; 23(5):382-391. PubMed ID: 35557039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing Type I and Type III CRISPR-Cas systems for genome editing.
    Li Y; Pan S; Zhang Y; Ren M; Feng M; Peng N; Chen L; Liang YX; She Q
    Nucleic Acids Res; 2016 Feb; 44(4):e34. PubMed ID: 26467477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA interference is controlled by R-loop length in a type I-F1 CRISPR-Cas system.
    Tuminauskaite D; Norkunaite D; Fiodorovaite M; Tumas S; Songailiene I; Tamulaitiene G; Sinkunas T
    BMC Biol; 2020 Jun; 18(1):65. PubMed ID: 32539804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Boolean gates show that Cas12c controls transcription activation effectively in the yeast
    Liu Y; Ge H; Marchisio MA
    Front Bioeng Biotechnol; 2023; 11():1267174. PubMed ID: 37771576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closely related type II-C Cas9 orthologs recognize diverse PAMs.
    Wei J; Hou L; Liu J; Wang Z; Gao S; Qi T; Gao S; Sun S; Wang Y
    Elife; 2022 Aug; 11():. PubMed ID: 35959889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient genome editing by CRISPR-Mb3Cas12a in mice.
    Wang Z; Wang Y; Wang S; Gorzalski AJ; McSwiggin H; Yu T; Castaneda-Garcia K; Prince B; Wang H; Zheng H; Yan W
    J Cell Sci; 2020 May; 133(9):. PubMed ID: 32393674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.